- About UNAIDS
- Our work
- Targets and commitments
- 2011 Political Declaration: Targets and elimination commitments
- Reducing sexual transmission
- Preventing HIV among drug users
- Eliminating new HIV infections among children
- 15 million accessing treatment
- Avoiding TB deaths
- Closing resource gap
- Eliminating gender inequalities
- Eliminating stigma and discrimination
- Eliminating travel restrictions
- Strengthening HIV integration
- 2011 Political Declaration: Targets and elimination commitments
More Office of the Chief Scientific Adviser to UNAIDS feature stories
- The quest for an HIV vaccine
- There is broad scientific consensus that getting to zero new HIV infections will require an HIV vaccine. Modelling shows that even a partially effective HIV vaccine can save many lives and dollars over time.
- Women need access to dual protection—effective contraceptives and HIV prevention options
- A stakeholder consultation convened by the World Health Organization (WHO) in Geneva has reviewed recent epidemiological studies related to HIV transmission and acquisition by women using hormonal contraceptives. After careful review of all available evidence, the stakeholders found that the data were not sufficiently conclusive to change current guidance.
- Time for action, say HIV science roundtable participants
- The roundtable was entitled Closing the gap between science and implementation: Accelerating science to get to South Africa’s vision of zero new HIV infections, and looked at ways of maximizing the opportunities created by scientific research around HIV prevention in the past year to reach the country’s target of halving new HIV infections by 2015.
- Where innovation meets implementation
- In 2010 an announcement was made by the Centre for the AIDS Programme of Research in South Africa (CAPRISA) which rocked the AIDS world and promised hope for millions of women around the world.
- New data from study roll-out provides further evidence that male circumcision is effective in preventing HIV in men
- The Joint United Nations Programme on HIV/AIDS (UNAIDS) strongly welcomes new results confirming that scaling-up adult male circumcision works to prevent HIV in men. The study, which was carried out in the township of Orange Farm in South Africa, resulted in a 55% reduction in HIV prevalence and a 76% reduction in HIV incidence in circumcised men.
- The Medicines Patent Pool announces negotiations with two additional pharmaceutical companies for patents on HIV medicines
- The Medicines Patent Pool announced that it has begun negotiations with Boehringer-Ingelheim and Bristol-Myers Squibb for patents on HIV medicines essential to treating people living with HIV in the developing world.
- 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention opens in Rome
- The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) opened in Rome on 17 July. More than 5 000 AIDS researchers, scientists, clinicians, community leaders and policy experts have gathered to examine the latest developments in HIV-related research and to explore how scientific advances can inform the global response to AIDS.
- UNAIDS and WHO hail new results showing that a once-daily pill for HIV-negative people can prevent them from acquiring HIV
- New data from studies in Kenya, Uganda and Botswana confirm major role of antiretroviral medicine in preventing heterosexual HIV transmission
- Groundbreaking trial results confirm HIV treatment prevents transmission of HIV
- WHO and UNAIDS hail results from the HPTN 052 trial that show antiretroviral therapy to be 96% effective in reducing HIV transmission in couples where one partner has HIV
- amfAR briefing highlights roadmap to accelerating an HIV prevention revolution
- As part of amfAR’s emerging issues series, a briefing was held on Capitol Hill, in Washington, D.C. on 9 March entitled "Accelerating an HIV Prevention Revolution: A Roadmap". Speaking at the briefing, UNAIDS Deputy Executive Director Paul De Lay stressed the need to scale up combination HIV prevention worldwide.
- ‘A better future’: New evidence shows triple antiretroviral drugs during pregnancy and breastfeeding can significantly reduce mother-to-child transmission of HIV
- The Lancet Infectious Diseases today published evidence from a World Health Organization-led study. The study showed that giving pregnant women living with HIV a combination of three antiretroviral (ARV) drugs from the last trimester, through delivery and six months of breastfeeding can reduce the risk of their babies being infected with HIV by more than 40%.
- Next steps with 1% tenofovir microbicide gel
- After nearly 20 years of research, the results of the CAPRISA 004 trial provided the first evidence that the use of a vaginal microbicide could provide a safe and effective way to prevent HIV infection in women.
- On International Women’s Day, UNAIDS, IAS and 14 partners launch new agenda to improve scientific research for women and children
- As the world marks International Women’s Day, there is growing concern that women and children are bearing the brunt of the AIDS epidemic. To turn the tide, UNAIDS, the International AIDS Society (IAS) and 14 other leading public and private sector organizations have teamed up to release a new scientific research agenda.
- During Winter Olympics, UNAIDS calls on Canada to ensure G8 delivers on universal access
- A global summit on HIV was hosted by LifeSciences British Columbia, the BC Centre of Excellence in HIV/AIDS, and the University of British Columbia (UBC) on 26 February against the backdrop of the 2010 Olympic Games. Endorsed by the International AIDS Society, the event "The Impact of Science & Innovation in the Evolving Global Health Paradigm: HIV and AIDS - A Challenge of Olympic Proportion" brought together world leaders in HIV research, health, innovation and policy to share latest and compelling perspectives on the challenges being faced under a shifting global health paradigm.
- Eastern Europe and Central Asia HIV conference for joint efforts towards Universal Access
- The 3rd HIV/AIDS Conference in Eastern Europe and Central Asia opened in Moscow today with a ceremony attended by senior representatives of Russian Duma, Russian Ministry of Foreign Affairs, Russian Academy of Sciences and the US Ambassador to the Russian Federation. Participants and organizers hope it will invigorate the regional response to the AIDS epidemic.
- Scientists come together for the AIDS Vaccine Conference 2009
- The yearly AIDS Vaccine Conference opened in Paris today. High on the agenda are discussions on the progress made in vaccine development and implications of trail results for the future.
- OPINION: HIV vaccine—a public good to right a global wrong
- The promise of a vaccine against HIV has got one step closer. Results from the largest vaccine trial ever conducted show a modest but encouraging 31% efficacy in preventing new HIV infections in Thailand. This has vindicated thousands of scientists and volunteers who have been hoping that a safe and highly effective HIV vaccine is possible.
- Largest ever HIV vaccine trial results very encouraging
- Geneva, 24 September 2009 – The World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) are optimistic about the results, announced today, of the largest ever HIV vaccine clinical trial held to date.
- Resources for regular lab tests could be used for HIV treatment
- Having 12 children and a very old mother to support, Vincent, middle-aged Ugandan single father living with HIV, knows that his death would spell disaster for the whole family. “If I had died, where would these people go?” said Vincent perched on a stool with his legs outstretched.
- Evidence shows new drug combination dramatically reduces mother-to child transmission of HIV during breastfeeding
- According to a new study led by WHO, if HIV-positive pregnant women are given a combination of antiretroviral drugs from late in pregnancy until six months into breastfeeding, rather than a short course of drugs that ends at delivery, their babies are over 40% less likely to become infected with HIV.